ロード中...

Monitoring therapeutic monoclonal antibodies in brain tumor

Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...

詳細記述

保存先:
書誌詳細
出版年:MAbs
主要な著者: Ait-Belkacem, Rima, Berenguer, Caroline, Villard, Claude, Ouafik, L’Houcine, Figarella-Branger, Dominique, Beck, Alain, Chinot, Olivier, Lafitte, Daniel
フォーマット: Artigo
言語:Inglês
出版事項: Taylor & Francis 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/
https://ncbi.nlm.nih.gov/pubmed/25484065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!